DUBLIN, Jan. 08, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/2b29v7/global_continuous) has announced the addition of the "Global Continuous Glucose Monitoring System - Glucose Sensors, Geographical Analysis, Artificial Pancreas, Size, Market Overview, Price, Industry Analysis, Market Growth, Market Share, Forecasts 2014 - 2020" report to their offering.
"Global Continuous Glucose Monitoring System (CGM Market, Real Time Monitoring, Integrated Insulin Pumps, Blood Glucose, Manufacturers, Global Health, IPRO Glucose, MARD, SMBG, Growing Diabetic Population, Type 1&2 Diabetes, Nocturnal Hypoglycemia) - Glucose Sensors, Geographical Analysis, Artificial Pancreas, Size, Market Overview, Price, Industry Analysis, Market Growth, Market Share, Forecasts 2014 - 2020"
Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from self-monitoring blood glucose devices (SMBG).
SMBG devices are cheaper and easy to use and have an less stringent approval process from authorities like FDA. SMBG has more number of players and larger market share. However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. CGM system market has seen good growth rates in past three years.
Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for paediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers.
Key Topics Covered:
1. EXECUTIVE SUMMARY
2. MARKET OVERVIEW
2.1. WHAT IS CGMS?
2.2. VALUE CHAIN ANALYSIS OF THE ROLE OF SUPPLER, MANUFACTURER AND END USER IN THE CGM MARKET
2.3. KEY BUYING CRITERIA
2.4. GAP ANALYSIS: UNREALISTIC GAP BETWEEN THE PROMISED PRODUCT AND DELIVERED PRODUCT
2.5. STRATEGIC RECOMMENDATION
3. MARKET DETERMINANTS
3.1. MARKET MOTIVATORS CGMS MARKET
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES IN CGMS MARKET
4. SECTOR ANALYSIS: DIABETES CARE
5. CGM MARKET BY DEVICES
6. BY APPLICATION
6.1. PROFESSIONAL CGMS (FOR HEALTHCARE PROFESSIONALS)
6.2. PERSONAL CGMS (FOR PATIENTS)
7. COMPETITIVE INTELLIGENCE
7.1. KEY STRATEGIES ENABLING CGMS MARKET TO INCREASE ACCEPTANCE
8. MARKET SHARE ANALYSIS
8.1. KEY COMPANY ANALYSIS
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.2. CANADA
9.3. EUROPE
9.4. ASIA PACIFIC
9.5. LATIN AMERICA
10. CORPORATE PROFILE: BENCHMARK STUDY
10.1. MEDTRONIC INC.
10.2. DEXCOM
10.3. ABBOTT
10.4. JOHNSON AND JOHNSON (ANIMAS CORP)
10.5. INSULET CORP
10.6. TANDEM DIABETES
10.7. ECHO THERAPEUTICS
For more information visit http://www.researchandmarkets.com/research/2b29v7/global_continuous
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
